You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 153 No. 8, 26 APR 1993 TABLE OF CONTENTS
  Archives
  •  Online Features
  Review Article
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Tissue Renin-Angiotensin System in Myocardial Hypertrophy and Failure

Victor J. Dzau, MD

Arch Intern Med. 1993;153(8):937-942.


Abstract

The renin-angiotensin system traditionally has been conceived as a neuroendocrine system functioning in the circulation. Recent research has confirmed the existence of autocrine/ paracrine tissue renin-angiotensin systems present and functioning at multiple sites, including cardiac, vascular, and renal tissues, which contain the majority of angiotensinconverting enzyme in the body. It appears that the circulating renin-angiotensin system is activated acutely to maintain homeostasis and is then turned off at cardiovascular compensation, while the tissue renin-angiotensin systems exert long-term actions that affect cardiovascular function and structure, which may play a pathophysiological role in congestive heart failure, hypertension, and vascular disease and influence the response to therapy with angiotensin-converting enzyme-inhibiting agents.

(Arch Intern Med. 1993;153:937-942)



Author Affiliations

From the Division of Cardiovascular Medicine and the Cardiovascular Research Center, Stanford University Medical Center, and the Falk Cardiovascular Research Center, Stanford, Calif.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Early expression of monocyte chemoattractant protein-1 correlates with the onset of isoproterenol-induced cardiac fibrosis in rats with distinct angiotensin-converting enzyme polymorphism
Copaja Soto et al.
Journal of Renin-Angiotensin-Aldosterone System 2008;9:154-162.
ABSTRACT  

Role of the C-344T aldosterone synthase gene variant in left ventricular mass and left ventricular structure-related phenotypes
Sookoian et al.
Heart 2008;94:903-910.
ABSTRACT | FULL TEXT  

Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals
Bodyak et al.
Proc. Natl. Acad. Sci. USA 2007;104:16810-16815.
ABSTRACT | FULL TEXT  

Predictors of Survival after Cardiac Arrest in Outpatient Hemodialysis Clinics
Pun et al.
CJASN 2007;2:491-500.
ABSTRACT | FULL TEXT  

Inhibition of prolyl 4-hydroxylase prevents left ventricular remodelling in rats with thoracic aortic banding
Fielitz et al.
Eur J Heart Fail 2007;9:336-342.
ABSTRACT | FULL TEXT  

Direct renin inhibition -- a new way of targeting the renin system
Brown
Journal of Renin-Angiotensin-Aldosterone System 2006;7:S7-S11.
ABSTRACT  

Eplerenone Shows Renoprotective Effect by Reducing LOX-1-Mediated Adhesion Molecule, PKC{epsilon}-MAPK-p90RSK, and Rho-Kinase Pathway
Kobayashi et al.
Hypertension 2005;45:538-544.
ABSTRACT | FULL TEXT  

Role of Angiotensin-Converting Enzyme Inhibitors in the Coronary Artery Bypass Patient
Lazar
Ann. Thorac. Surg. 2005;79:1081-1089.
ABSTRACT | FULL TEXT  

Cardiac and renal effects of omapatrilat, a vasopeptidase inhibitor, in rats with experimental congestive heart failure
Abassi et al.
Am. J. Physiol. Heart Circ. Physiol. 2005;288:H722-H728.
ABSTRACT | FULL TEXT  

Diabetes Mellitus, the Renin-Angiotensin-Aldosterone System, and the Heart
Lim et al.
Arch Intern Med 2004;164:1737-1748.
ABSTRACT | FULL TEXT  

Increased ACE 2 and Decreased ACE Protein in Renal Tubules From Diabetic Mice: A Renoprotective Combination?
Ye et al.
Hypertension 2004;43:1120-1125.
ABSTRACT | FULL TEXT  

Depletion of Tissue Angiotensin-Converting Enzyme Differentially Influences the Intrarenal and Urinary Expression of Angiotensin Peptides
Modrall et al.
Hypertension 2004;43:849-853.
ABSTRACT | FULL TEXT  

Addition of Valsartan to an Angiotensin-Converting Enzyme Inhibitor Improves Cardiac Sympathetic Nerve Activity and Left Ventricular Function in Patients with Congestive Heart Failure
Kasama et al.
JNM 2003;44:884-890.
ABSTRACT | FULL TEXT  

Therapeutic Role of Angiotensin II Receptor Blockers in the Treatment of Heart Failure
Manohar and Pina
Mayo Clin Proc. 2003;78:334-338.
ABSTRACT  

Mice Lacking Endothelial ACE: Normal Blood Pressure With Elevated Angiotensin II
Cole et al.
Hypertension 2003;41:313-321.
ABSTRACT | FULL TEXT  

Angiotensinogen 235T Allele "Dosage" Is Associated With Blood Pressure Phenotypes
Pereira et al.
Hypertension 2003;41:25-30.
ABSTRACT | FULL TEXT  

Role of AT2 Receptors in the Cardioprotective Effect of AT1 Antagonists in Mice
Xu et al.
Hypertension 2002;40:244-250.
ABSTRACT | FULL TEXT  

Gradual reactivation over time of vascular tissue angiotensin I to angiotensin II conversion during chronic lisinopril therapy in chronic heart failure
Farquharson and Struthers
J Am Coll Cardiol 2002;39:767-775.
ABSTRACT | FULL TEXT  

A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
Cohn et al.
NEJM 2001;345:1667-1675.
ABSTRACT | FULL TEXT  

Losartan in the Therapy of Heart Failure Patients
Berezin
Asian Cardiovasc. Thorac. Ann. 2001;9:302-307.
ABSTRACT | FULL TEXT  

Current Perspectives on the Use of Gene Therapy for Hypertension
Gelband et al.
Circ. Res. 2000;87:1118-1122.
ABSTRACT | FULL TEXT  

Inhibitory Effect of Angiotensin II Type 2 Receptor on Coronary Arterial Remodeling After Aortic Banding in Mice
Akishita et al.
Circulation 2000;102:1684-1689.
ABSTRACT | FULL TEXT  

Gene therapy for hypertension and restenosis
Gardon et al.
Journal of Renin-Angiotensin-Aldosterone System 2000;1:211-216.
 

ACE Inhibition Versus Angiotensin-II Antagonism in Heart Failure
Kumar et al.
Asian Cardiovasc. Thorac. Ann. 2000;8:195-203.
ABSTRACT | FULL TEXT  

Improvement of cardiac output in patients with severe heart failure by use of ACE-inhibitors combined with the AT1-antagonist eprosartan
Gremmler et al.
Eur J Heart Fail 2000;2:183-187.
ABSTRACT | FULL TEXT  

Aminopeptidase-A. I. cDNA cloning and expression and localization in rat tissues
Troyanovskaya et al.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000;278:R413-R424.
ABSTRACT | FULL TEXT  

Measurement of the Renin-Angiotensin System in Heart Failure
Kim
Biol Res Nurs 2000;1:210-226.
ABSTRACT  

Dynamic Ca2+ signalling in rat arterial smooth muscle cells under the control of local renin-angiotensin system
Asada et al.
J. Physiol. 1999;521:497-505.
ABSTRACT | FULL TEXT  

Is antisense gene therapy a step in the right direction in the control of hypertension?
Raizada et al.
Am. J. Physiol. Heart Circ. Physiol. 1999;277:H423-H432.
FULL TEXT  

Effects of Eprosartan on Renal Function and Cardiac Hypertrophy in Rats With Experimental Heart Failure
Brodsky et al.
Hypertension 1998;32:746-752.
ABSTRACT | FULL TEXT  

Asynchronous Electrical Activation Induces Asymmetrical Hypertrophy of the Left Ventricular Wall
van Oosterhout et al.
Circulation 1998;98:588-595.
ABSTRACT | FULL TEXT  

Intraadrenal Interactions in the Regulation of Adrenocortical Steroidogenesis
Ehrhart-Bornstein et al.
Endocr. Rev. 1998;19:101-143.
ABSTRACT | FULL TEXT  

Myocardial and plasma renin-angiotensinogen dynamics during pressure-induced cardiac hypertrophy
Heller et al.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 1998;274:R849-R856.
ABSTRACT | FULL TEXT  

Tissue-Specific Regulation of Renal and Cardiac Atrial Natriuretic Factor Gene Expression in Deoxycorticosterone Acetate–Salt Rats
Ogawa et al.
Hypertension 1997;30:1342-1347.
ABSTRACT | FULL TEXT  

Increased Expression of Interleukin-1ß and Monocyte Chemotactic and Activating Factor/Monocyte Chemoattractant Protein-1 in the Hypertrophied and Failing Heart With Pressure Overload
Shioi et al.
Circ. Res. 1997;81:664-671.
ABSTRACT | FULL TEXT  

Passive Load and Angiotensin II Evoke Differential Responses of Gene Expression and Protein Synthesis in Cardiac Myocytes
Kent and McDermott
Circ. Res. 1996;78:829-838.
ABSTRACT | FULL TEXT  

A competitive deletion mutant quantitative PCR assay for angiotensin-converting enzyme mRNA in smooth muscle cells.
Lanzillo et al.
Genome Res 1994;4:167-171.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.